PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))

Term ID

CHEBI:89151

Synonyms

1-(11-Eicosenoyl)-2-(8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Eicosenoyl-2-eicsoate
1-Eicosenoyl-2-eicsoatetraenoyl-sn-glycero-3-phosphoinositol
1-Eicosenoyl-2-eicsoic acid
[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(20:1/20:4)
Phosphatidylinositol(20:1n9/20:4n3)
Phosphatidylinositol(20:1w9/20:4w3)
Phosphatidylinositol(40:5)
PI(20:1/20:4)
PI(20:1n9/20:4n3)
PI(20:1w9/20:4w3)
PI(40:5)
PIno(20:1/20:4)
PIno(20:1n9/20:4n3)
PIno(20:1w9/20:4w3)
PIno(40:5)

(all 17)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))

Phenotype where environments contain PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))

Phenotype modified by environments containing PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))

Phenotype affecting PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))

Human Disease Model